Literature DB >> 28730475

Characterization of Ligand Binding to Pseudokinases Using a Thermal Shift Assay.

Isabelle S Lucet1, James M Murphy2,3.   

Abstract

The protocol herein describes a robust and proven method for the measurement of pseudokinase-ligand interaction using a fluorescence-based thermal shift assay (TSA). Pseudokinases are kinase-like proteins that have recently emerged as crucial regulatory modules of signal transduction pathways and may well represent a novel class of drug targets. However, unlike kinases, the regulatory activity of pseudokinases is mainly conferred through protein-protein interactions. Understanding the mechanisms that underlie pseudokinase conformational changes through ligand binding and how such conformational changes can tune signaling pathways is a necessary step to unravel their biological functions.Thermal denaturation-based methods have proven to be a powerful method for determining the capacity of purified recombinant pseudokinases to bind ligands and can simultaneously inform on the potential druggability of the nucleotide-binding site. This assay takes advantage of a change in fluorescence arising when the dye, SYPRO Orange, binds to hydrophobic patches that become exposed when a protein undergoes thermal unfolding. Ligand binding to a protein is known to increase its thermal stability, which is reflected by a shift between the thermal denaturation curves of the unliganded protein and the liganded protein. Here, we illustrate the utility of the method with the pseudokinases, ErbB3/HER3, ILK, ROP5Bi, JAK1, JAK2, TYK2, MLKL, STRAD, TRIB1, VRK3, and ROR1. This method can also be used to determine optimal buffer conditions that may increase protein stability and can be tailored to other protein families.

Entities:  

Keywords:  ATP mimetics; Kinase inhibitors; Kinases; Nucleotides; Pseudokinases; Thermal stability shift assay

Mesh:

Substances:

Year:  2017        PMID: 28730475     DOI: 10.1007/978-1-4939-7154-1_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease.

Authors:  Baisen Zhong; Weiyu Peng; Shan Du; Bingyi Chen; Yajuan Feng; Xinfeng Hu; Qi Lai; Shujie Liu; Zhong-Wei Zhou; Pengfei Fang; Yan Wu; Feng Gao; Huihao Zhou; Litao Sun
Journal:  Small Sci       Date:  2022-03-13

2.  How Physiologic Targets Can Be Distinguished from Drug-Binding Proteins.

Authors:  Kojo Mensa-Wilmot
Journal:  Mol Pharmacol       Date:  2021-05-03       Impact factor: 4.054

3.  AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition.

Authors:  Kai-Li Zhang; Qian-Qian Shen; Yan-Fen Fang; Yi-Ming Sun; Jian Ding; Yi Chen
Journal:  Acta Pharmacol Sin       Date:  2019-06-06       Impact factor: 6.150

4.  Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1.

Authors:  Nicholas P D Liau; Artem Laktyushin; Rhiannon Morris; Jarrod J Sandow; Nicos A Nicola; Nadia J Kershaw; Jeffrey J Babon
Journal:  Cancers (Basel)       Date:  2019-11-01       Impact factor: 6.639

5.  Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.

Authors:  Yanxiang Meng; Katherine A Davies; Cheree Fitzgibbon; Samuel N Young; Sarah E Garnish; Christopher R Horne; Cindy Luo; Jean-Marc Garnier; Lung-Yu Liang; Angus D Cowan; Andre L Samson; Guillaume Lessene; Jarrod J Sandow; Peter E Czabotar; James M Murphy
Journal:  Nat Commun       Date:  2021-11-22       Impact factor: 14.919

6.  Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance.

Authors:  Laura Ramos Garcia; Tencho Tenev; Richard Newman; Rachel O Haich; Gianmaria Liccardi; Sidonie Wicky John; Alessandro Annibaldi; Lu Yu; Mercedes Pardo; Samuel N Young; Cheree Fitzgibbon; Winnie Fernando; Naomi Guppy; Hyojin Kim; Lung-Yu Liang; Isabelle S Lucet; Andrew Kueh; Ioannis Roxanis; Patrycja Gazinska; Martin Sims; Tomoko Smyth; George Ward; John Bertin; Allison M Beal; Brad Geddes; Jyoti S Choudhary; James M Murphy; K Aurelia Ball; Jason W Upton; Pascal Meier
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

7.  Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis.

Authors:  Emma J Petrie; Jarrod J Sandow; Annette V Jacobsen; Brian J Smith; Michael D W Griffin; Isabelle S Lucet; Weiwen Dai; Samuel N Young; Maria C Tanzer; Ahmad Wardak; Lung-Yu Liang; Angus D Cowan; Joanne M Hildebrand; Wilhelmus J A Kersten; Guillaume Lessene; John Silke; Peter E Czabotar; Andrew I Webb; James M Murphy
Journal:  Nat Commun       Date:  2018-06-21       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.